These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 3213790

  • 21. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG, Berg C, Fornander AM, Nilsson MA.
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [Abstract] [Full Text] [Related]

  • 22. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M, Shakhssalim N, Basiri A, Miladipour AH, Golestan B, Mohammadi Torbati P, Azadvari M, Eftekhari S.
    Urol J; 2011 Mar; 8(2):99-106. PubMed ID: 21656467
    [Abstract] [Full Text] [Related]

  • 23. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [Abstract] [Full Text] [Related]

  • 24. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B, Rahman MA.
    Biomed Pharmacother; 1986 Nov; 40(3):108-10. PubMed ID: 3742009
    [Abstract] [Full Text] [Related]

  • 25. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A, Meschi T, Schianchi T, Allegri F, Novarini A, Borghi L.
    Acta Biomed; 2002 Nov; 73(1-2):11-26. PubMed ID: 12233273
    [Abstract] [Full Text] [Related]

  • 26. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A.
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [Abstract] [Full Text] [Related]

  • 27. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W, Minevich E, Jackson E, Reddy P, Clark C, Sheldon C, Asplin J.
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [Abstract] [Full Text] [Related]

  • 28. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M, Anders D, Graef V, Bödeker RH.
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [Abstract] [Full Text] [Related]

  • 29. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S, Morimoto S, Yoshida T, Fukatani T, Yasukawa S, Okawa T.
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [Abstract] [Full Text] [Related]

  • 30. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK, Sutton RA.
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [Abstract] [Full Text] [Related]

  • 31. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW, Thorson S, Randolph A.
    Trans Am Assoc Genitourin Surg; 1979 Aug; 71():62-6. PubMed ID: 161827
    [Abstract] [Full Text] [Related]

  • 32. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E.
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [Abstract] [Full Text] [Related]

  • 33. [Oxalate loading test for outpatients with calcium oxalate stones].
    Kato M.
    Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
    [Abstract] [Full Text] [Related]

  • 34. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.
    Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BE.
    N Engl J Med; 1976 Jan 29; 294(5):249-52. PubMed ID: 1244550
    [Abstract] [Full Text] [Related]

  • 35. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.
    Robertson WG, Hughes H.
    Scanning Microsc; 1993 Mar 29; 7(1):391-401; discussion 401-2. PubMed ID: 8316808
    [Abstract] [Full Text] [Related]

  • 36. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B.
    Ther Umsch; 2003 Feb 29; 60(2):79-87. PubMed ID: 12649986
    [Abstract] [Full Text] [Related]

  • 37. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
    Fleming DE, Van Riessen A, Chauvet MC, Grover PK, Hunter B, van Bronswijk W, Ryall RL.
    J Bone Miner Res; 2003 Jul 29; 18(7):1282-91. PubMed ID: 12854839
    [Abstract] [Full Text] [Related]

  • 38. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M.
    Urol Int; 2003 Jul 29; 70(4):273-7. PubMed ID: 12740490
    [Abstract] [Full Text] [Related]

  • 39. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL.
    J Urol; 2002 Jun 29; 167(6):2372-6. PubMed ID: 11992040
    [Abstract] [Full Text] [Related]

  • 40. Surface phase transition of hydrated calcium oxalate crystal in the presence of normal and stone-formers' urine.
    Akbarieh M, Tawashi R.
    Scanning Microsc; 1990 Jun 29; 4(2):387-93; discussion 393-4. PubMed ID: 2402611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.